News headlines about Natera (NASDAQ:NTRA) have been trending somewhat positive this week, Accern reports. The research firm identifies negative and positive press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Natera earned a news impact score of 0.17 on Accern’s scale. Accern also gave news coverage about the medical research company an impact score of 44.9385306146098 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
Shares of Natera (NTRA) opened at $10.10 on Friday. Natera has a fifty-two week low of $7.35 and a fifty-two week high of $14.76. The company has a quick ratio of 1.75, a current ratio of 1.85 and a debt-to-equity ratio of 2.43. The firm has a market cap of $544.68 and a PE ratio of -4.16.
Natera (NASDAQ:NTRA) last posted its earnings results on Wednesday, November 8th. The medical research company reported ($0.51) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.47) by ($0.04). The business had revenue of $56.66 million during the quarter, compared to the consensus estimate of $55.31 million. Natera had a negative return on equity of 197.09% and a negative net margin of 62.34%. The business’s quarterly revenue was up 5.1% on a year-over-year basis. During the same quarter last year, the firm earned ($0.50) earnings per share. research analysts anticipate that Natera will post -2.15 earnings per share for the current year.
Several brokerages have recently weighed in on NTRA. Morgan Stanley reiterated an “overweight” rating and set a $16.00 price target (up previously from $13.00) on shares of Natera in a research note on Friday, October 6th. Zacks Investment Research upgraded shares of Natera from a “sell” rating to a “buy” rating and set a $15.00 target price on the stock in a research note on Wednesday, October 11th. Robert W. Baird reiterated a “buy” rating on shares of Natera in a report on Tuesday, October 24th. Cowen reiterated a “buy” rating and issued a $12.00 price target on shares of Natera in a report on Thursday, December 21st. Finally, Canaccord Genuity reiterated a “buy” rating and issued a $15.00 price target on shares of Natera in a report on Tuesday, November 14th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and four have issued a buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $14.50.
ILLEGAL ACTIVITY WARNING: This report was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this report on another publication, it was copied illegally and reposted in violation of international copyright & trademark legislation. The original version of this report can be read at https://www.dispatchtribunal.com/2018/01/12/somewhat-positive-media-coverage-somewhat-unlikely-to-impact-natera-ntra-share-price-3.html.
Natera Company Profile
Receive News & Ratings for Natera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natera and related companies with MarketBeat.com's FREE daily email newsletter.